Cita APA

Lahiguera, Á., Hyroššová, P., Figueras, A., Garzón, D., Moreno, R., Soto-Cerrato, V., & Serra Elizalde, V. (2020). Tumors defective in homologous recombination rely on oxidative metabolism: Relevance to treatments with PARP inhibitors.

Citación estilo Chicago

Lahiguera, Álvaro, Petra Hyroššová, Agnès Figueras, Diana Garzón, Roger Moreno, Vanessa Soto-Cerrato, y Violeta Serra Elizalde. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.

Cita MLA

Lahiguera, Álvaro, et al. Tumors Defective in Homologous Recombination Rely On Oxidative Metabolism: Relevance to Treatments With PARP Inhibitors. 2020.